↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Hromadka T) "

Search: WFRF:(Hromadka T)

Result 1-3 of 3

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Novak, P, et al. (author) ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease 2021 In: Nature aging. - : Springer Science and Business Media LLC. - 2662-8465. ; 1:6, s. 521-534 Journal article (peer-reviewed)
2.	Novak, P, et al. (author) ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease 2021 In: Nature aging. - : Springer Science and Business Media LLC. - 2662-8465. ; 1:6, s. 521- Journal article (peer-reviewed)
3.	Vogels, Thomas, 1987, et al. (author) Tau Pathology in Neurodegenerative Diseases 2022 In: Neurodegenerative Diseases Biomarkers. Neuromethods, vol 173. Peplow P.V., Martinez B., Gennarelli T.A. (eds). - New York, NY : Springer. - 0893-2336. - 9781071617120 ; , s. 71-97 Book chapter (other academic/artistic)abstract Aggregation and cellular accumulation of tau protein is a defining feature of tauopathies, a class of histopathologically and clinically heterogeneous neurodegenerative diseases. Tauopathies include diseases as diverse as Alzheimer’s disease (AD), Pick’s disease, progressive supranuclear palsy, corticobasal degeneration, and chronic traumatic encephalopathy. Tau pathology affects different cell types in various tauopathies and strongly correlates with clinical symptoms. The complexity of tau pathology and the structural diversity of tau aggregates in different tauopathies represent an active area of research in neurodegeneration. The initiation, spreading, and cellular clearance of tau pathology play important roles in the disease process of tauopathies. Spreading of tau pathology throughout the brain may underlie the progressive nature of these diseases. Understanding of mechanisms underlying the spreading of tau pathology between neurons and glial cells is essential for the development and use of emerging therapeutics and tau biomarkers. Recent biomarkers have enabled identification of the earliest stages of AD pathology and tracking the anatomical progression of tau pathology over time. An increasing number of tau-targeting therapeutics are entering clinical trials and might lead to the development of a treatment for these devastating neurodegenerative disorders. © 2022, Springer Science+Business Media, LLC, part of Springer Nature.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-3 of 3

Refine your search

Type of publication: journal article (2); book chapter (1)

Type of content: peer-reviewed (2); other academic/artistic (1)

Author/Editor: Hromadka, T (3); Winblad, B (2); Hort, J (2); Schmidt, R (2); Novak, P (2); Harrison, J (2); show more...; Novak, M (2); Scheltens, P (2); Froelich, L (2); Otto, M. (2); Kramberger, M (2); Ropele, S. (2); Stevens, E (2); Hanes, J. (2); Tosun, D. (2); Kovacech, B. (2); Zilka, N. (2); Katina, S (2); Kontsekova, E (2); Fialova, L (2); Paulenka-Ivanovova, ... (2); Smisek, M (2); Kovac, A (2); Sutovsky, S (2); Parrak, V (2); Koson, P (2); Prcina, M (2); Galba, J (2); Cente, M (2); Filipcik, P (2); Piestansky, J (2); Samcova, M (2); Prenn-Gologranc, C (2); Sivak, R (2); Fresser, M (2); Rakusa, M (2); Ondrus, M (2); Vogels, Thomas, 1987 (1); show less...

University: Karolinska Institutet (2); University of Gothenburg (1)

Language: English (3)

Research subject (UKÄ/SCB): Medical and Health Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view